Key facts
- This page summarizes David Duane House's Form 4 filing for Armata Pharmaceuticals, Inc. (ARMP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 11 Mar 2026, 21:17.
David Duane House - 09 Mar 2026 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)
- Reporting relationship
- SVP, Finance, and PFO
- Issuer ticker
- ARMP
- Reported as of
- 09 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Mar 2026, 21:17:29 UTC
- Prior SEC filing
- 07 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Duane House
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David Duane House filed Form 4 for Armata Pharmaceuticals, Inc. (ARMP) on 11 Mar 2026.
Change
- Previous filing in this sequence was filed on 07 Feb 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002034219
Primary reporting owner
House David Duane
- Relationship
- SVP, Finance, and PFO
- Address
- 5005 MCCONNELL AVENUE, LOS ANGELES
- Signature
- /s/ David Duane House
- Signature date
- 11 Mar 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ARMP
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- Shares
- +109,885
- Change %
- Price
- $0.000000*
- Shares after
- 109,885
- Date
- 09 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 109,885
- Exercise price
- $11.61
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Twenty-five percent (25%) of the Stock Options shall vest on March 9th of each of 2027, 2028, 2029, and 2030, in each case subject to continuous service through the applicable vesting date.